Simron Singh

Oral cavity and oropharyngeal squamous cell carcinoma—an update

Multidisciplinary cancer care: Does it improve outcomes?

ePAD: An Image Annotation and Analysis Platform for Quantitative Imaging

Sexual dimorphism in cancer

Prognostic factors in metastatic gastric cancer: results of a population-based, retrospective cohort study in Ontario

Panitumumab plus radiotherapy versus chemoradiotherapy in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-2): a randomised, controlled, open-label phase 2 trial

ESPEN guideline: Clinical nutrition in surgery

Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial

Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment

Macrophages in immunoregulation and therapeutics

EGF–ERBB signalling: towards the systems level

Asthma

Inflammation and tumor progression: signaling pathways and targeted intervention

Sex and gender: modifiers of health, disease, and medicine

Preparing Medical Imaging Data for Machine Learning

Prognostic value of chemotherapy-induced neutropenia in early-stage breast cancer

Malignant Gliomas in Adults

Targeting Epidermal Growth Factor Receptor in Head and Neck Cancer

Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trials

Gastric cancer

Metabolic reprogramming in macrophage responses

Prevalence of Malnutrition Among Gastric Cancer Patients Undergoing Gastrectomy and Optimal Preoperative Nutritional Support for Preventing Surgical Site Infections

Safety and cost analysis of an 18FDG-PET-CT response based follow-up strategy for head and neck cancers treated with primary radiation or chemoradiation

Neutrophils in cancer: neutral no more

The effectiveness of e-Health interventions on caregiver burden, depression, and quality of life in informal caregivers of patients with cancer: A systematic review and meta-analysis of randomized controlled trials

Chemotherapy for advanced gastric cancer

Identification of a high‐risk subtype of intestinal‐type Japanese gastric cancer by quantitative measurement of the luminal tumor proportion

Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States

A phase II basket trial of Dual Anti–CTLA–4 and Anti–PD–1 Blockade in Rare Tumors (DART) SWOG S1609: High‐grade neuroendocrine neoplasm cohort

Where Is the Evidence? A Systematic Review of Shared Decision Making and Patient Outcomes

Phase I Single-Dose Study of Intracavitary-Administered Iodine-131-TM-601 in Adults With Recurrent High-Grade Glioma

Exploring the rising incidence of neuroendocrine tumors: A population‐based analysis of epidemiology, metastatic presentation, and outcomes

Activity & safety of spartalizumab (PDR001) in patients (pts) with advanced neuroendocrine tumors (NET) of pancreatic (Pan), gastrointestinal (GI), or thoracic (T) origin, & gastroenteropancreatic neuroendocrine carcinoma (GEP NEC) who have progressed on prior treatment (Tx)

Shared decision making in oncology: assessing oncologist behaviour in consultations in which adjuvant therapy is considered after primary surgical treatment

The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Midgut Neuroendocrine Tumors

The Value of Periodic Follow-up in the Detection of Recurrences after Radical Treatment in Locally Advanced Head and Neck Cancer

A systematic review of patient surveillance after curative gastrectomy for gastric cancer: a brief review

Chemoradiotherapy with or without panitumumab in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-1): a randomised, controlled, open-label phase 2 trial

A systematic review of surgery for non-curative gastric cancer

Multidisciplinary Reference Centers: The Care of Neuroendocrine Tumors

Influence of Sex on Toxicity and Treatment Outcome in Small-Cell Lung Cancer

Everolimus in advanced, progressive, well‐differentiated, non‐functional neuroendocrine tumors: RADIANT‐4 lung subgroup analysis